Why the study?
ACS is a major cause of mortality and morbidity worldwide, and this study aimed to predict AF in ACS patients receiving ticagrelor or clopidogrel using tissue Doppler-derived atrial dyssynchrony.
Does ticagrelor compared to clopidogrel affect the incidence of atrial fibrillation or electro-echocardiographic AF predictors in patients with acute coronary syndromes?
Observational (n=200)
No
Does ticagrelor compared to clopidogrel affect the incidence of atrial fibrillation or electro-echocardiographic AF predictors in patients with acute coronary syndromes?
Answers are grounded in this paper and cite their sources.
The choice between ticagrelor and clopidogrel does not significantly impact electro-echocardiographic predictors of atrial fibrillation in patients with acute coronary syndromes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ebaid et al. (2023) conducted an observational in Acute coronary syndromes (ACS) (n=200). Ticagrelor vs. Clopidogrel was evaluated on Incidence of AF and electro-echocardiographic AF predictors.
Synapse has enriched 10 related papers. Consider them for comparative context: